V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20197633 | 20152762 | 1.83 | 87.6 | Palliative (P) | 2017-09-22 | 2017-10-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101420353 |
| 20197634 | 20152763 | 1.67 | 116 | null | 2019-08-08 | 2019-08-08 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100452542 |
| 20197635 | 20152764 | 1.6 | 42.9 | Palliative (P) | 2016-07-26 | 2016-08-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101356032 |
| 20197637 | 20152765 | 1.69 | 55.1 | Palliative (P) | 2017-06-16 | 2017-06-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101646815 |
| 20197638 | 20152766 | 1.68 | 50 | Adjuvant (A) | 2017-09-27 | 2017-11-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101472583 |
| 20197641 | 20152767 | 1.67 | 98 | null | 2020-05-20 | 2020-06-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100221085 |
| 20197642 | 20152768 | 1.64 | 66.7 | Palliative (P) | 2019-11-13 | 2019-12-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101695761 |
| 20197643 | 20152769 | 1.78 | 52.2 | Palliative (P) | 2016-10-10 | 2016-10-17 | Docetaxel | 02 | N | DOCETAXEL | 100877789 |
| 20197648 | 20152770 | 1.7 | 58.3 | Palliative (P) | 2019-05-09 | 2019-05-26 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101697265 |
| 20197651 | 20152771 | 1.7 | 56 | Palliative (P) | 2019-12-13 | 2020-01-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100704484 |
| 20197655 | 20152772 | 1.77 | 98.6 | 03 | 2017-04-24 | 2017-07-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100081257 |
| 20197656 | 20152773 | 1.88 | 58.4 | Neo-adjuvant (N) | 2017-05-15 | 2017-07-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100589614 |
| 20197658 | 20152774 | 1.67 | 77.9 | Palliative (P) | 2017-11-06 | 2017-11-13 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100711071 |
| 20197661 | 20152775 | 1.69 | 58.2 | null | 2018-08-15 | 2018-08-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101773295 |
| 20197663 | 20152776 | 1.76 | 70.5 | null | 2020-04-15 | 2020-04-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100138817 |
| 20197664 | 20152777 | 1.84 | 74.4 | null | 2019-11-18 | 2019-11-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100401837 |
| 20197666 | 20152778 | 1.66 | 88.2 | Palliative (P) | 2019-09-03 | 2019-09-14 | Docetaxel | 02 | N | DOCETAXEL | 100156877 |
| 20197676 | 20152779 | 1.72 | 77.8 | Palliative (P) | 2015-08-23 | 2015-08-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101181074 |
| 20197678 | 20152780 | 1.55 | 57 | Palliative (P) | 2018-02-09 | 2018-02-27 | Docetaxel | 02 | N | DOCETAXEL | 100724262 |
| 20197680 | 20152781 | 1.66 | 43.3 | null | 2016-12-19 | 2016-12-25 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100371078 |
| 20197682 | 20152782 | 1.6 | 78.3 | Palliative (P) | 2020-05-25 | 2020-05-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101697222 |
| 20197684 | 20152783 | 1.76 | 49 | null | null | null | Docetaxel | 02 | null | DOCETAXEL | 100366631 |
| 20197694 | 20152784 | 1.83 | 82.6 | Palliative (P) | 2018-10-29 | 2018-10-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100150951 |
| 20197702 | 20152785 | 1.74 | 87.7 | null | 2019-03-21 | 2019-05-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100873501 |
| 20197708 | 20152786 | 1.61 | 68.7 | Palliative (P) | 2020-08-27 | 2021-07-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100617118 |
| 20197709 | 20152787 | 1.6 | 50.7 | Adjuvant (A) | 2021-11-20 | 2021-11-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100707180 |
| 20197723 | 20152788 | 1.85 | 69.3 | Neo-adjuvant (N) | 2018-05-12 | 2018-09-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101497801 |
| 20197724 | 20152789 | 1.67 | 88.8 | Neo-adjuvant (N) | 2016-11-24 | 2016-12-09 | Docetaxel | 02 | N | DOCETAXEL | 101247931 |
| 20197725 | 20152790 | 1.63 | 133.7 | Palliative (P) | 2017-06-26 | 2017-06-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101213870 |
| 20197727 | 20152791 | 1.85 | 60.2 | Palliative (P) | 2016-05-02 | 2016-05-13 | Docetaxel | N | N | DOCETAXEL | 101733252 |
| 20197728 | 20152792 | 1.66 | 89.6 | Palliative (P) | 2017-06-11 | 2017-07-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101851204 |
| 20197738 | 20152793 | 1.63 | 53.5 | Palliative (P) | 2017-02-04 | 2017-02-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100779808 |
| 20197739 | 20152794 | 1.67 | 73.3 | null | 2016-08-28 | 2016-09-07 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100029079 |
| 20197752 | 20152795 | 1.59 | 46 | Palliative (P) | 2017-09-26 | 2017-11-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101668111 |
| 20197758 | 20152796 | 1.74 | 65.5 | Adjuvant (A) | 2020-09-13 | 2021-01-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101859254 |
| 20197762 | 20152797 | 1.67 | 89 | Palliative (P) | 2020-09-25 | 2020-10-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100760922 |
| 20197767 | 20152798 | 1.83 | 64.6 | Curative (C) | 2020-08-16 | 2020-08-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101541615 |
| 20197770 | 20152799 | 1.57 | 83 | Palliative (P) | 2019-10-27 | 2019-11-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101037876 |
| 20197773 | 20152800 | 1.61 | 107.7 | Palliative (P) | 2019-12-01 | 2019-12-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101237791 |
| 20197781 | 20152801 | 1.67 | 102 | null | 2018-04-27 | 2018-06-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100101839 |
| 20197795 | 20152802 | 1.88 | 71 | null | 2016-07-16 | 2016-07-30 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101668541 |
| 20197796 | 20152803 | 1.69 | 49.8 | Palliative (P) | 2018-04-20 | 2018-04-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101279916 |
| 20197811 | 20152804 | 1.55 | null | Palliative (P) | 2017-01-02 | 2017-01-11 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101657593 |
| 20197813 | 20152805 | 1.68 | 99.6 | null | 2017-05-03 | 2017-05-17 | Docetaxel | 02 | null | DOCETAXEL | 100694900 |
| 20197815 | 20152806 | null | 45.8 | Palliative (P) | 2021-04-05 | 2021-04-08 | Cetuximab + FOLFIRI cycle 2 onwards | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101400614 |
| 20197825 | 20152807 | 1.76 | 75.2 | Palliative (P) | 2018-02-26 | 2018-03-17 | Docetaxel | 02 | N | DOCETAXEL | 101722217 |
| 20197831 | 20152808 | 1.83 | 65.8 | Palliative (P) | 2016-08-26 | 2016-09-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101749888 |
| 20197838 | 20152809 | 1.52 | 66.3 | Palliative (P) | 2015-01-01 | 2015-01-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101620537 |
| 20197846 | 20152810 | 1.7 | 66.8 | Neo-adjuvant (N) | 2018-03-08 | 2018-05-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100449750 |
| 20197848 | 20152811 | 1.62 | 88.2 | null | 2018-10-09 | 2018-10-14 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101505982 |